226 related articles for article (PubMed ID: 22927250)
1. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor dose links development to disease.
Sigvardsson M
Blood; 2012 Nov; 120(18):3630-1. PubMed ID: 23118213
[No Abstract] [Full Text] [Related]
3. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes.
Anderson K; Rusterholz C; Månsson R; Jensen CT; Bacos K; Zandi S; Sasaki Y; Nerlov C; Sigvardsson M; Jacobsen SE
Blood; 2007 May; 109(9):3697-705. PubMed ID: 17218387
[TBL] [Abstract][Full Text] [Related]
4. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
Sekine R; Kitamura T; Tsuji T; Tojo A
Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
[TBL] [Abstract][Full Text] [Related]
5. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
[TBL] [Abstract][Full Text] [Related]
7. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
8. The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.
Itoh-Nakadai A; Hikota R; Muto A; Kometani K; Watanabe-Matsui M; Sato Y; Kobayashi M; Nakamura A; Miura Y; Yano Y; Tashiro S; Sun J; Ikawa T; Ochiai K; Kurosaki T; Igarashi K
Nat Immunol; 2014 Dec; 15(12):1171-80. PubMed ID: 25344725
[TBL] [Abstract][Full Text] [Related]
9. Losing B cell identity.
Carotta S; Nutt SL
Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
11. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
12. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
Heavey B; Charalambous C; Cobaleda C; Busslinger M
EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
[TBL] [Abstract][Full Text] [Related]
13. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
17. miR-221 redirects precursor B cells to the BM and regulates their residence.
Knoll M; Simmons S; Bouquet C; Grün JR; Melchers F
Eur J Immunol; 2013 Sep; 43(9):2497-506. PubMed ID: 23716169
[TBL] [Abstract][Full Text] [Related]
18. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
19. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
Cotta CV; Zhang Z; Kim HG; Klug CA
Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
[TBL] [Abstract][Full Text] [Related]
20. Expression of essential B cell development genes in horses with common variable immunodeficiency.
Tallmadge RL; Such KA; Miller KC; Matychak MB; Felippe MJ
Mol Immunol; 2012 Jun; 51(2):169-76. PubMed ID: 22464097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
